This report is the result of extensive primary research into the insurance regulatory framework in Papua New Guinea. It provides detailed analysis of the insurance regulations governing life, property, motor, liability, personal accident and health, and marine, aviation and transit insurance, and specifies the requirements for the establishment and operation of insurance and reinsurance companies and intermediaries.

The report provides insurers, reinsurers, brokers, and investors with authoritative information on prevailing insurance regulations and recent and upcoming changes in the regulatory framework, taxation, and legal system in Papua New Guinea. The scope of non-admitted insurance in the country is also covered.

Key Highlights:

- The Papua New Guinean insurance industry is regulated by the Insurance Commissioner operating under the Bank of Papua New Guinea
- 100% foreign direct investment is permitted subject to regulatory approval
- Non-admitted insurance is prohibited with limited exceptions requiring prior approval from the Insurance Commissioner $1,495.00 ]]> Mon, 26 Nov 2018 15:59:59 +0000 https://www.leadingmarketresearch.com/world-clinical-chemistry-and-immunodiagnostic-analyzers-and-reagents-market

This new 98-country survey from LeadingMarketResearch.com is available by geographic region, country, market segment, section, or individual test.

This new 11-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

Rationale

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic Technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. ...

This new 22-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

Rationale

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. ...

This new 18-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

This report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers. ...

This new 38-country report from LeadingMarketResearch.com is available by country, market segment, section, or individual test.

The report is available by section, and can be customized to specific information needs and budget.

This report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers. ...

- Will the industry consolidate, decentralize, or undergo a bimodal transformation?

- How will the current trends affect the major market segments?

- Which companies will enter the market and which will not survive?

The companies analyzed in this report include:

Aesculap Arthrex DePuy Synthes Enovis Globus Medical Medtronic NuVasive Ossur Smith & Nephew Stryker Zimmer Biomet

Individual company reports $750.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs.

The analysis includes:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

In the dynamic and fragmented Orthopedics industry, besieged by intense competition and rapid change of technological innovations, the ability to anticipate new product introductions and marketing strategies is particularly important...and can spell the differen...

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:

- Latest organizational and management developments - Acquisitions and divestitures - Marketing tactics - Financial results - Strengths and weaknesses - Strategic directions

The objectives of the report include:

- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors. - To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates. - To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.

The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs....

This new 92-country survey from LeadingMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the automated microbiology market during the next five years. The report examines key trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for 100 molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

The following are the latest Molecular Diagnostics Market research and technology assessment reports that might interest you and your colleagues:

- World Molecular Diagnostic Instrumentation and Reagents for 100 Tests: A 68-Country Market Analysis

- Molecular Diagnostics: US, Europe, Japan—Segment Forecasts for 100 Tests and Supplier Shares by Country

- Molecular Diagnostics Country Reports: Asia-Pacific, Europe, Latin America, Middle East, North America $0.00 ]]> Mon, 04 Nov 2019 12:03:24 +0000 https://www.leadingmarketresearch.com/opportunities-in-molecular-diagnostics

This new 92-country survey from LeadingMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.